OLMA · Olema Pharmaceuticals, Inc.
$11.58
-0.18 (-1.53%)
At close · Aug 5
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$985.28M
Shares
87.35M
Olema Pharmaceuticals, Inc. Earnings Call Transcripts
Every quarterly earnings call for Olema Pharmaceuticals, Inc. (OLMA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Conference
Investor event
2026-06-09
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-26
Olema Pharmaceuticals, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.52
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-18
Olema Pharmaceuticals, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q1
2024-05-08
Olema Pharmaceuticals, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-0.56
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
31 filings
31 filers
Visit website
Investor relations